Tero-Pekka Alastalo

Tero-Pekka Alastalo, MD, PhD is the President and Chief Medical Officer CardioSignal Inc. He is a health care entrepreneur, investor, advisor, and board member. He has 10+ years of clinical and translational research experience and is an Adjunct Professor of Pediatrics at the University of Helsinki. He specialized in Pediatric Cardiology and did his postdoctoral training at Stanford University. He was a co-founder of Blueprint Genetics, a genetic testing laboratory for human rare diseases, that was acquired by Quest Diagnostics in 2020. At Blueprint Genetics he had several executive roles from commerci
© 2022 HLTH, LLC All Rights Reserved